Role of helical CT pulmonary angiography in risk stratification for patients with pulmonary embolism

Thomas H. Urbania, Michael Gotway, Michael D. Hope, David M. Naeger, Karen G. Ordovas, Brett M. Elicker

Research output: Contribution to journalReview article

Abstract

Initial risk stratification for patients with pulmonary embolism (PE) is based on clinical assessment and rapidly separates those who are hemodynamically stable from those who are unstable. Unstable patients have a high short-term mortality and are candidates for thrombolysis. A subset of stable patients will have right ventricular dysfunction placing them at increased risk for PE-related mortality. Further risk stratification that can reliably distinguish this subset of patients from those who will have an uneventful course may justify expanding the indication for thrombolysis to include this high-risk group. Current risk stratification methods focus on comorbid conditions, ECG, blood gas analysis, serum biomarkers, and echocardiography. Computed tomography (CT) pulmonary angiography (CTPA) is principally used for the diagnosis of PE, but because CTPA is obtained very early in the evaluation of patients with suspected PE, there is interest in its potential role as a risk stratification tool. CT findings of right ventricular dysfunction and CT scores quantifying the degree of pulmonary arterial obstruction have been studied as possible risk stratification parameters. This study briefly reviews clinical risk stratification schemes before undertaking a more in-depth review of the research regarding the potential role of CTPA as a risk stratification tool for patients with PE.

Original languageEnglish (US)
Pages (from-to)230-237
Number of pages8
JournalClinical Pulmonary Medicine
Volume18
Issue number5
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Spiral Computed Tomography
Pulmonary Embolism
Lung
Right Ventricular Dysfunction
Tomography
Computed Tomography Angiography
Blood Gas Analysis
Mortality
Echocardiography
Electrocardiography
Biomarkers

Keywords

  • computed tomography pulmonary angiography
  • prognosis
  • pulmonary embolism
  • risk stratification
  • thrombolysis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Role of helical CT pulmonary angiography in risk stratification for patients with pulmonary embolism. / Urbania, Thomas H.; Gotway, Michael; Hope, Michael D.; Naeger, David M.; Ordovas, Karen G.; Elicker, Brett M.

In: Clinical Pulmonary Medicine, Vol. 18, No. 5, 09.2011, p. 230-237.

Research output: Contribution to journalReview article

Urbania, Thomas H. ; Gotway, Michael ; Hope, Michael D. ; Naeger, David M. ; Ordovas, Karen G. ; Elicker, Brett M. / Role of helical CT pulmonary angiography in risk stratification for patients with pulmonary embolism. In: Clinical Pulmonary Medicine. 2011 ; Vol. 18, No. 5. pp. 230-237.
@article{37010c6363e6441e95805a5c39b1d91f,
title = "Role of helical CT pulmonary angiography in risk stratification for patients with pulmonary embolism",
abstract = "Initial risk stratification for patients with pulmonary embolism (PE) is based on clinical assessment and rapidly separates those who are hemodynamically stable from those who are unstable. Unstable patients have a high short-term mortality and are candidates for thrombolysis. A subset of stable patients will have right ventricular dysfunction placing them at increased risk for PE-related mortality. Further risk stratification that can reliably distinguish this subset of patients from those who will have an uneventful course may justify expanding the indication for thrombolysis to include this high-risk group. Current risk stratification methods focus on comorbid conditions, ECG, blood gas analysis, serum biomarkers, and echocardiography. Computed tomography (CT) pulmonary angiography (CTPA) is principally used for the diagnosis of PE, but because CTPA is obtained very early in the evaluation of patients with suspected PE, there is interest in its potential role as a risk stratification tool. CT findings of right ventricular dysfunction and CT scores quantifying the degree of pulmonary arterial obstruction have been studied as possible risk stratification parameters. This study briefly reviews clinical risk stratification schemes before undertaking a more in-depth review of the research regarding the potential role of CTPA as a risk stratification tool for patients with PE.",
keywords = "computed tomography pulmonary angiography, prognosis, pulmonary embolism, risk stratification, thrombolysis",
author = "Urbania, {Thomas H.} and Michael Gotway and Hope, {Michael D.} and Naeger, {David M.} and Ordovas, {Karen G.} and Elicker, {Brett M.}",
year = "2011",
month = "9",
doi = "10.1097/CPM.0b013e31822ca103",
language = "English (US)",
volume = "18",
pages = "230--237",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Role of helical CT pulmonary angiography in risk stratification for patients with pulmonary embolism

AU - Urbania, Thomas H.

AU - Gotway, Michael

AU - Hope, Michael D.

AU - Naeger, David M.

AU - Ordovas, Karen G.

AU - Elicker, Brett M.

PY - 2011/9

Y1 - 2011/9

N2 - Initial risk stratification for patients with pulmonary embolism (PE) is based on clinical assessment and rapidly separates those who are hemodynamically stable from those who are unstable. Unstable patients have a high short-term mortality and are candidates for thrombolysis. A subset of stable patients will have right ventricular dysfunction placing them at increased risk for PE-related mortality. Further risk stratification that can reliably distinguish this subset of patients from those who will have an uneventful course may justify expanding the indication for thrombolysis to include this high-risk group. Current risk stratification methods focus on comorbid conditions, ECG, blood gas analysis, serum biomarkers, and echocardiography. Computed tomography (CT) pulmonary angiography (CTPA) is principally used for the diagnosis of PE, but because CTPA is obtained very early in the evaluation of patients with suspected PE, there is interest in its potential role as a risk stratification tool. CT findings of right ventricular dysfunction and CT scores quantifying the degree of pulmonary arterial obstruction have been studied as possible risk stratification parameters. This study briefly reviews clinical risk stratification schemes before undertaking a more in-depth review of the research regarding the potential role of CTPA as a risk stratification tool for patients with PE.

AB - Initial risk stratification for patients with pulmonary embolism (PE) is based on clinical assessment and rapidly separates those who are hemodynamically stable from those who are unstable. Unstable patients have a high short-term mortality and are candidates for thrombolysis. A subset of stable patients will have right ventricular dysfunction placing them at increased risk for PE-related mortality. Further risk stratification that can reliably distinguish this subset of patients from those who will have an uneventful course may justify expanding the indication for thrombolysis to include this high-risk group. Current risk stratification methods focus on comorbid conditions, ECG, blood gas analysis, serum biomarkers, and echocardiography. Computed tomography (CT) pulmonary angiography (CTPA) is principally used for the diagnosis of PE, but because CTPA is obtained very early in the evaluation of patients with suspected PE, there is interest in its potential role as a risk stratification tool. CT findings of right ventricular dysfunction and CT scores quantifying the degree of pulmonary arterial obstruction have been studied as possible risk stratification parameters. This study briefly reviews clinical risk stratification schemes before undertaking a more in-depth review of the research regarding the potential role of CTPA as a risk stratification tool for patients with PE.

KW - computed tomography pulmonary angiography

KW - prognosis

KW - pulmonary embolism

KW - risk stratification

KW - thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=80052699085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052699085&partnerID=8YFLogxK

U2 - 10.1097/CPM.0b013e31822ca103

DO - 10.1097/CPM.0b013e31822ca103

M3 - Review article

AN - SCOPUS:80052699085

VL - 18

SP - 230

EP - 237

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 5

ER -